Structure (Nabumetone Tablet 1)
Nabumetone
Product Images NDC 0440-5844
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 0440-5844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Liberty Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
6mna (Nabumetone Tablet 2)
Figure (Nabumetone Tablet 3)
This is a graph that shows the plasma concentrations of Nabumetone Active Metabolite (MNA) at steady state, following once-daily dosing of nabumetone of 1000 mg and 2000 mg. The graph displays the concentration in mega/mL over time in hours. The group of 1000 mg has 31 subjects while the 2000 mg has 12 subjects. There are error bars SD (Standard Deviation) for both groups to illustrate the variability of the data.*
Image (Nabumetone Tablet 4)
Image (Nabumetone Tablet 5)
This is a prescription drug sold by Liberty Pharmaceuticals Inc. under the brand name RXONLY. The medicine contains NABUMETONE, USP 750MG and is sold in a package of 90 tablets. The tablets are white, oval-shaped, imprinted with "257" on one side and "APO" on the other. The drug is used to treat inflammation and pain caused by arthritis. It is intended for use in government medical facilities only and commercial use is strictly prohibited. The manufacturer is Exelan Pharmaceuticals Inc based in Lawrenceville, GA with an expiry date of BL1ASOPN.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
